United States · FDA National Drug Code directory
Auranofin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85437-093_42776e01-ac39-5aa4-e063-6294a90a99e9
- Product NDC
- 85437-093
- Form
- CAPSULE
- Composition / generic term
- auranofin
- Labeler
- Coral Way Pharma, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20251029
- Source listing expiry
- 20261231
Source-listed ingredients
- AURANOFIN — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (85437-093-06) · 85437-093-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →